Results 11 to 20 of about 2,421 (106)

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study. [PDF]

Cancer
Abstract Background Real‐world data are an essential complement to clinical trials. This is particularly true for chronic lymphocytic leukemia, where five first‐line options have never been directly compared. Methods The authors present the results of a national multicenter real‐world study focusing on treatment choices in frontline chronic lymphocytic
Coste A, Sritharan N, Lok A, Tomowiak C, Ferrant E, Clavert A, Roos-Weil D, Bouclet F, Caillet A, Croizier C, Stocker N, Tchernonog E, Feugier P, Santagostino A, Hivert B, Michallet AS, De Guibert S, Lara D, Waultier-Rascalou A, Merabet F, Durand A, Bussot L, Laribi K, Dilhuydy MS, Lévy V, Quinquenel A.   +25 more
europepmc   +2 more sources

A novel JK-null allele due to splicing variant. [PDF]

Transfusion
Transfusion, Volume 66, Issue 5, Page 1036-1038, May 2026.
Tournamille C, Fichou Y, Benech C, Muralitharan V, Levy C, Heng E, Bouly N, Floch A.   +7 more
europepmc   +2 more sources

A novel RHCE*cE689C allele (p.Ser230Thr) in 2 donors of European ancestry with discrepant E antigen typing. [PDF]

Transfusion
Transfusion, Volume 66, Issue 5, Page 1034-1035, May 2026.
Neto Braga G, Tournamille C, Le Maréchal C, Flahaut R, Ricard C, Floch A.   +5 more
europepmc   +2 more sources

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia. [PDF]

Br J Haematol
British Journal of Haematology, Volume 208, Issue 5, Page 1867-1872, May 2026.
Sorin B, Azzouguen B, Loustau V, Boutin E, Henique H, Graveleau J, Souchaud-Debouverie O, Pascal L, Gilardin L, Costedoat-Chalumeau N, Reynaud Q, Pan-Petesch B, Cheze S, Terriou L, Comont T, Sauvetre G, Royer B, Mahévas M, Michel M, Canoui-Poitrine F, Godeau B, Guillet S.   +21 more
europepmc   +2 more sources

T-Cell Acute Lymphoblastic Leukemia in a Young Patient With Andersen-Tawil Syndrome Successfully and Safely Treated With Intensive Chemotherapy Including Potential Precipitating Drugs: A Case Report After 3.5 Years of Follow-up. [PDF]

EJHaem
ABSTRACT Andersen–Tawil syndrome (ATS) is a rare, hereditary channelopathy characterized by periodic paralysis, cardiac arrhythmias, and sometimes developmental anomalies. No association with hematologic malignancies has previously been reported. We describe the case of a 27‐year‐old man with genetically confirmed Type 1 ATS who developed T‐cell acute ...
Rahmé R, Bamba PM, Do TTD, Behin A, Gandjbakhch E, Gardin C, Braun T.   +6 more
europepmc   +2 more sources

Persistent <i>BCR::ABL1</i>-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL. [PDF]

Hemasphere
HemaSphere, Volume 10, Issue 5, May 2026.
Martin JE, Cliquot J, Kim R, Mathis S, Cayuela JM, Passet M, Gaillard B, Himberlin C, Baruchel A, Itzykson R, Soulier J, Boissel N, Raffoux E, Cornillet-Lefebvre P, Clappier E.   +14 more
europepmc   +2 more sources

Quelques effets cliniques, hématologiques et biochimiques de quatre tranquillisants chez les dromadaires

Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1989
Six dromadaires sains ont été traités avec les tranquillisants suivants : propionyl promazine (CombelenND), xylazine (RompunND), acépromazine (CalmivetND) ou chlorpromazine (LargactffND) avec une dose unique de 0,5, 0,25, 0,1 ou 3 mg/kg respectivement ...
B.H. Ali, A.A. El Sanhouri, B.E. Musa
doaj   +1 more source

Etude des constantes biologiques du sang du cerf rusa (Cervus timorensis russa) en Nouvelle-Calédonie. I. Les constantes hématologiques

Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1989
Depuis le début de l’année 1987, l’élevage du cerf rusa (Cervus timorensis russa) se développe en Nouvelle-Calédonie. En 1988, au cours d’une opération d’abattage en élevage, l’auteur a réalisé près de 90 prélèvements de sang pour définir les constantes
Laurent Audigé
doaj   +1 more source

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

Scientific Reports, 2021
Accumulation in target cells is an essential pharmacokinetic step of targeted therapies. Tyrosine Kinase Inhibitors (TKI) against the BCR-ABL fusion protein in Chronic Phase-Chronic Myeloid Leukaemia (CP-CML) cells constitute a unique model in terms of ...
Marc G. Berger, Benjamin Lebecque, Thomas Tassin, Louis-Thomas Dannus, Juliette Berger, Mélanie Soucal, Agnès Guerci, Pascale Cony-Makhoul, Hyacinthe Johnson, Gabriel Etienne, Denis Guyotat, Marie-Claude Gagnieu, Bruno Pereira, Sandrine Saugues, Olivier Tournilhac, Eric Hermet, Céline Bourgne   +16 more
doaj   +1 more source

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma

Medical Sciences, 2023
In primary central nervous system lymphoma, two-year progression-free survival rates of up to 63 percent have been reported for first-line autologous stem cell transplantation after conditioning with the thiotepa busulfan cyclophosphamide regimen ...
Lebon Delphine, Debureaux Pierre-Edouard, Royer Bruno, Gruson Bérengère, Joris Magalie, Votte Patrick, Marolleau Jean-Pierre, Morel Pierre   +7 more
doaj   +1 more source